Skip to main content


Media Coverage

CRISPR Dispute Likely to Continue in Federal Courts

8 December 2016
Life Sciences Intellectual Property Review (subscription required)
Intellectual Property partner Brian Nolan (New York) was quoted in this article discussing the CRISPR/Cas9 patent hearing on December 6 between The Broad Institute and University of California, Berkeley (UCB).
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.